Adolescent Idiopathic Scoliosis – Clínica Bas

TOMORROW´S HEALTHCARE, TODAY

EpiDisease SL is an innovative Spanish biotechnology company that has positioned itself as a pioneer in the research and development of clinical tools based on genetic and epigenetic advances. With over 10 years of dedication and effort, EpiDisease SL is committed to offering solutions that deliver the healthcare of the future, today. Its flagship product, ScoliGEN, is a clear example of its scientific and cutting-edge work, providing a test that enables more precise and personalized management of children with AIS.

At EpiDisease, science and health come together to transform medical care and provide patients with the best opportunities for their well-being.

At EpiDisease SL, we are excited to announce our collaboration with Clínica Bas to offer cutting-edge in vitro diagnostic (IVD) tools: ScoliGEN and ScoliMIR. These innovative solutions, developed after 10 years of research and development, are specifically designed for patients with Adolescent Idiopathic Scoliosis (AIS) and their families. The availability of ScoliGEN and ScoliMIR at Clínica Bas represents a global milestone in the integration of genetics and epigenetics into scoliosis management. These tools enable a precision and personalized approach, providing physicians with valuable information that can guide clinical decisions and improve outcomes and quality of life for children affected by this condition, and their families.

The Clínica Bas Team

With over 30 years of experience, Dr. Teresa Bas Hermida is the director of Clínica Bas, where she leads a team of renowned spine specialists in Valencia.

Dr. Teresa Bas Hermida was one of the first female spine surgeons in Spain, making her a true pioneer in the field.

She combines her clinical practice with research, serving as the Principal Investigator of the project on Identification of Biomarkers Based on Circulating MicroRNAs for the Diagnosis and Prognosis of Adolescent Idiopathic Scoliosis (AIS). Alongside other researchers, she has developed biomarkers that allow for the diagnosis and prognosis of AIS through a blood test.

On another front, Dr. Bas Hermida and her team have performed a pioneering scoliosis correction surgery in Spain on a fourteen-year-old patient. Her outstanding professional career has been recognized with the award as one of the 25 best orthopedic surgeons in Spain.

She is considered one of the most prestigious orthopedic and trauma surgeons in Spain. She currently serves as Head of the Spine Unit at the University and Polytechnic Hospital La Fe (Valencia), Head of the Multidisciplinary Spinal Pathology Unit at the same hospital (a national reference unit), and Associate Professor at the Faculty of Medicine of the University of Valencia, Department of Surgery, Unit of Traumatology and Orthopedic Surgery.

Her career as a spine surgeon has earned her numerous awards and recognitions, establishing her as a leading national and international expert in advanced and complex spinal surgery.

Dr. Paloma Bas Hermida is a key member of the Clínica Bas team, thanks to her vast experience as a spine surgeon. XXXXXXXXXXXX

What are ScoliGEN and ScoliMIR?

ScoliGEN: This genetic tool assesses the genetic profile, identifying variants that may influence the progression of scoliosis. With this information, physicians can personalize treatment plans for each child and more effectively plan how they respond to the evolution of the condition.

ScoliGEN is currently available

ScoliMIR: This epigenetic tool provides information on how environmental and lifestyle factors can affect gene expression related to scoliosis. With this information, physicians can diagnose and predict spinal progression, as well as monitor the effectiveness of conservative interventions, adapting, optimizing, and personalizing their approach to each case.

ScoliMIR is currently under regulatory review. It is expected to be commercially available to patients in the fourth quarter of 2024.

A Personalized Approach for Each Patient

The collaboration between EpiDisease SL and Clínica Bas not only represents an advancement in medical technology, but also reflects our shared commitment to improving the quality of life for young people with AIS. By bringing the power of genetics and epigenetics closer to treatment, we are empowering physicians and families to make informed, data-driven decisions. We are excited about the future and the positive impact that ScoliGEN and ScoliMIR will have on the lives of patients and their families. Together, we are paving the way toward a more effective and personalized approach to managing adolescent idiopathic scoliosis. For more information on how these tools can benefit your family, please do not hesitate to contact the physicians at Clínica Bas.